Navigation Links
Migenix in Medical News

New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report

... Albuferon II-58 Intarcia Releases Study Results of Omega Interferon II-58 Nautilus Biotech Commences Phase I Study for Belerofon(R) II-58 migenix Announces Phase II Proof-of-Concept Study Results of Celgosivir II-59 Pharmasset Begins Multiple Dose-Escalating Study of R7128 II-59 Tran...

MIGENIX Reports Preliminary Celgosivir Viral Kinetics Study

...ER, and SAN DIEGO, Dec. 3 /PRNewswire-FirstCall/ - migenix Inc. (TSX: MGI, OTC: MGIFF), a clinical-stage deve...of sustained treatment response. About MIGENIX migenix is committed to advancing therapy, improving healt...e treatment of dermatological diseases (Phase II). migenix is headquartered in Vancouver, British Columbia, C...
Migenix in Medical Technology

Cutanea Announces Promising Phase II Results in Rosacea with Omiganan

...usive worldwide rights for dermatological uses to a novel, cationic, antimicrobial peptide, whose active component is omiganan pentahydrochloride from migenix Inc., a British Columbia Corporation located in Vancouver, BC, Canada (TSX: MGI; OTC: MGIFF). Omiganan is in development as a topical treatment for pa...

New Clinical Study Results Indicate Higher Early Virologic Response with Celgosivir Combination Therapy in HCV Non-Responders

...DIEGO, CA, April 11, 2007 /PRNewswire-FirstCall/ - migenix Inc. , a clinical-stage developer of drugs for inf...ng-Plough Corporation ("Schering") having informed migenix that approximately 50% of the original viral load ...sen, M.D., Vice President, Clinical Development of migenix stated, "the increase in EVR to 42% after retestin...

Migenix to Present Celgosivir Phase II Hepatitis C Results at Digestive Disease Week 2007

...versity of Manitoba and a lead investigator in the migenix Phase II study will make the presentation. The p...sen, M.D., Vice President, Clinical Development of migenix will participate in a DDW news conference highligh...s to improve efficacy in anti-HCV therapy. About migenix ...
Migenix in Biological Technology

Notice of MIGENIX General Meeting of Shareholders

VANCOUVER and SAN DIEGO, July 24 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases, advises that the directors of MIGENIX Inc. have called a general meeting of shareholders (the "Meeting") to be held at 2:00 p.m. (Vancouve...

MIGENIX Reports First Quarter Fiscal 2009 Financial Results

... VANCOUVER, Sept. 15 /PRNewswire-FirstCall/ - migenix Inc. (the "Company" or "MIGENIX") (TSX: MGI; OTC: ...or the three months ended July 31, 2008 ("Q1/09"), migenix incurred a loss of $2.6 million (Q1/08: $3.1 milli...of the convertible royalty participation units). migenix believes that its funds on hand at July 31, 2008 a...

Migenix averts proxy contest; reaches agreement with DJohnson holdings

... VANCOUVER, Aug. 11 /PRNewswire-FirstCall/ - migenix Inc. ("MIGENIX") announced today that it has reach...ed for October 31, 2008. As part of the agreement, migenix has reduced the size of its board of directors fro...NIX, commented: "We are pleased a solution between migenix and DJohnson has been reached. As a result of a de...

MIGENIX Fourth Quarter and Fiscal Year 2008 Financial Results Conference Call & Webcast Notification

...website at http://www.migenix.com for the next 90 days. About MIGENIX migenix is committed to advancing therapy, improving health, and enriching life by ...ns (preclinical) and the treatment of hepatitis B infections (preclinical). migenix is headquartered in Vancouver, British Columbia, Canada with US operations ...

MIGENIX Corporate Update and Requisition of Special Meeting

...VER and SAN DIEGO, July 8 /PRNewswire-FirstCall/ - migenix Inc. (TSX: MGI, OTC: MGIFF), a clinical-stage deve...ent and the board maintain their commitment to all migenix shareholders to create value based on our existing...Update"). Jim DeMesa, M.D., President and CEO of migenix stated, "Since announcing our strategic plan in 20...

Migenix Takes Operational Actions To Extend Cash Past Upcoming Key Milestones

...VER and SAN DIEGO, May 27 /PRNewswire-FirstCall/ - migenix Inc. (TSX: MGI, OTC: MGIFF), a clinical-stage deve..." below). Jim DeMesa, M.D., President and CEO of migenix stated, "We must preserve our cash during this ver...actions are expected to achieve both. All of us at migenix are committed to creating value for our shareholde...

MIGENIX Appoints Pieter Dorsman to Board of Directors

...R and SAN DIEGO, April 21 /PRNewswire-FirstCall/ - migenix Inc. (TSX: MGI, OTC: MGIFF), a clinical-stage deve...r ten years of service. David Scott, Chairman of migenix stated, "We owe a great deal to Mr. Mallet for his... company over the coming years." About MIGENIX migenix is committed to advancing therapy, improving healt...

MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results

...R and SAN DIEGO, March 13 /PRNewswire-FirstCall/ - migenix Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage deve...s programs. Jim DeMesa, M.D., President & CEO of migenix stated, "With the conclusion of our third fiscal q...09. Under the terms of the agreement with Cadence, migenix will receive up to US$27 million in development an...

MIGENIX Third Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification

...R and SAN DIEGO, March 11 /PRNewswire-FirstCall/ - migenix Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage deve...genix.com for the next 90 days. About MIGENIX migenix is committed to advancing therapy, improving healt...treatment of hepatitis B infections (preclinical). migenix is headquartered in Vancouver, British Columbia, C...

MIGENIX releases CEO message #22

...o available on SEDAR and EDGAR). About MIGENIX migenix is committed to advancing therapy, improving healt...e treatment of dermatological diseases (Phase II). migenix is headquartered in Vancouver, British Columbia, C...or accuracy of this release. CONTACT: Art Ayres, migenix Inc., Tel: (604) 221-9666 Ext. 233, aayres@migenix...
Other Tags
(Date:7/31/2014)... David Kekich, anti-aging icon and CEO of Age ... the acceptance of his revolutionary approach of extracting ... and then screening thousands of compounds against genetic ... “It took longer than I thought and millions ... Kekich. "Client acceptance is exploding, early clinical trial ...
(Date:7/31/2014)... The North American Colorants Market report ... America with analysis and forecast of volume growth. ... American Colorants Market report, to get an idea ... a glimpse of the segmentation in the North ... tables and figures. , http://www.micromarketmonitor.com/market/americas-colorants-8463333110.html ...
(Date:7/31/2014)... York, NY (PRWEB) July 31, 2014 ... Ovarian Cancer Coalition will be featured in the ... space is being donated by EHE International, an ... care management. The eye-catching window display, designed in ... flip-flops symbolizing women’s footsteps, in a ratio that ...
(Date:7/31/2014)... July 31, 2014 Ohio Presbyterian Retirement ... The Sarah Moore Health Care Center, Inc. (Sarah Moore HCC) ... in ownership control. The not-for-profit Sarah Moore HCC was established ... years, the Sarah Moore HCC has grown and developed an ... , "The Sarah Moore HCC has been an integral part ...
(Date:7/31/2014)... release is available in German . ... baby blues after giving birth. Some even develop full-blown ... A, an enzyme responsible for the breakdown of neurotransmitters ... this condition. In comparison to healthy women, women who ... enzyme in their brains. This was discovered by a ...
Breaking Medicine News(10 mins):Health News:MaxLife Solution™ Expands Distribution Globally for Breakthrough Anti-Inflammatory Support Supplement – InflaGene™ 2Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:National Ovarian Cancer Coalition to be Featured in New York’s Rockefeller Center Window during August to Raise Awareness and Promote Education about Ovarian Cancer 2Health News:National Ovarian Cancer Coalition to be Featured in New York’s Rockefeller Center Window during August to Raise Awareness and Promote Education about Ovarian Cancer 3Health News:Ohio Presbyterian Retirement Services Welcomes The Sarah Moore HCC into Its Family 2Health News:Ohio Presbyterian Retirement Services Welcomes The Sarah Moore HCC into Its Family 3Health News:Monoamine oxidase A: Biomarker for postpartum depression 2Health News:Monoamine oxidase A: Biomarker for postpartum depression 3
(Date:7/30/2014)... Lewis Carroll,s Through the Looking Glass, collaborators from ... Singapore improved a 35-year-old ecology model to better ... of years. , The new model, called a ... Queen Effect," an evolutionary hypothesis introduced by Lee ... organisms must constantly increase their fitness (or ability ...
(Date:7/30/2014)... (ACS) announced today that David L. Kaplan, Ph.D., will ... & Engineering as editor-in-chief. With the first issue ... will feature high-quality research in the rapidly burgeoning field ... materials that interact with living or biological systems. , ... tremendous growth in the field of biomaterials over the ...
(Date:7/30/2014)... Everybody knows the shortest distance between two points is ... that sperm have been taking the familiar axiom to ... usually thought to be intense, with each racing for ... in some species, sperm form cooperative groups that allow ... , A new study, conducted by Heidi Fisher, ...
Breaking Biology News(10 mins):Classic Lewis Carroll character inspires new ecological model 2Classic Lewis Carroll character inspires new ecological model 3ACS Biomaterials Science & Engineering: Brand-new journal launches in 2015, names editor 2When cooperation counts 2When cooperation counts 3
Other Contents